Literature DB >> 11316171

Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy.

Z Hassoun1, M Deschênes, M Lafortune, M P Dufresne, P Perreault, L Lepanto, D Gianfelice, B Bui, G Pomier-Layrargues.   

Abstract

OBJECTIVE: In the present study we evaluated the predictive value of pretransjugular intrahepatic portosystemic shunt (TIPS) portal perfusion as assessed by Doppler ultrasonography for the onset of chronic encephalopathy after TIPS.
METHODS: A total of 231 cirrhotic patients were followed-up prospectively after TIPS placement. The pattern of intrahepatic portal flow was assessed before TIPS. Patients were divided into two groups according to Doppler findings. Group 1 comprised patients with prograde portal flow (n = 200), whereas group 2 comprised those with loss of portal perfusion (hepatofugal or back-and-forth flow or portal vein thrombosis; n = 31). The presence of chronic encephalopathy during a median follow-up of 32 months was prospectively recorded. The prognostic value of the following parameters for the onset of chronic recurrent encephalopathy after TIPS was evaluated: age, presence of encephalopathy before TIPS, alcoholism, Pugh score, and loss of portal perfusion before TIPS. The independent prognostic value of each variable was tested with a multiple logistic regression analysis.
RESULTS: The two groups were comparable in terms of age, incidence of prior episodes of hepatic encephalopathy, and portacaval gradient before and after the procedure; however, liver failure was more severe in patients in group 2 (Pugh score: 9.2 +/- 1.9 vs 10.3 +/- 1.7). The 3-yr survival was identical for both groups; 25% of the 200 patients in group 1 developed chronic encephalopathy as compared to 6% of the 31 patients in group 2 (p = 0.03). Multiple logistic regression analysis demonstrated that loss of portal perfusion and age >65 yr were the only independent predictors of the onset of post-TIPS chronic encephalopathy (odds ratios 0.24 and 1.98, respectively).
CONCLUSIONS: Cirrhotic patients with loss of portal perfusion before TIPS were protected against post-TIPS chronic hepatic encephalopathy despite a more severe liver dysfunction at baseline. The only other independent predictive factor for the onset of this complication was age.

Entities:  

Mesh:

Year:  2001        PMID: 11316171     DOI: 10.1111/j.1572-0241.2001.03704.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  16 in total

1.  Transjugular intrahepatic porto-systemic shunt in the elderly: Palliation for complications of portal hypertension.

Authors:  Mubin I Syed; Hetal Karsan; Hector Ferral; Azim Shaikh; Uzma Waheed; Talal Akhter; Alan Gabbard; Kamal Morar; Robert Tyrrell
Journal:  World J Hepatol       Date:  2012-02-27

Review 2.  The brain following transjugular intrahepatic portosystemic shunt: the perspective from neuroimaging.

Authors:  Hui Juan Chen; Gang Zheng; Julian L Wichmann; U Joseph Schoepf; Guang Ming Lu; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2015-09-24       Impact factor: 3.584

3.  Emergent stent occlusion for TIPS-induced liver failure.

Authors:  David C Wolf; Saima Siddiqui; Yaser Rayyan; Grigory Rozenblit
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

Review 4.  Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up.

Authors:  Alexander Copelan; Baljendra Kapoor; Mark Sands
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

5.  A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt.

Authors:  Yinglong Li; Xiaofeng He; Huajin Pang
Journal:  Turk J Gastroenterol       Date:  2019-08       Impact factor: 1.852

6.  Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.

Authors:  Paolo Fonio; Andrea Discalzi; Marco Calandri; Andrea Doriguzzi Breatta; Laura Bergamasco; Silvia Martini; Antonio Ottobrelli; Dorico Righi; Giovanni Gandini
Journal:  Radiol Med       Date:  2017-05-16       Impact factor: 3.469

Review 7.  Current use of transjugular intrahepatic portosystemic shunts.

Authors:  Timothy M McCashland
Journal:  Curr Gastroenterol Rep       Date:  2003-02

8.  Single-Centre Retrospective Training Cohort Using Artificial Intelligence for Prognostic Prediction of Encephalopathy, Mortality, and Liver Dysfunction after Early TIPS Creation.

Authors:  Bin-Yan Zhong; Wan-Sheng Wang; Jian Shen; Hang Du; Shuai Zhang; Wan-Ci Li; Yu Yin; Jun Yang; Cai-Fang Ni; Xiao-Li Zhu
Journal:  Cardiovasc Intervent Radiol       Date:  2021-07-08       Impact factor: 2.740

9.  Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS).

Authors:  Lukas Sturm; Dominik Bettinger; Max Giesler; Tobias Boettler; Arthur Schmidt; Nico Buettner; Robert Thimme; Michael Schultheiss
Journal:  United European Gastroenterol J       Date:  2018-08-15       Impact factor: 4.623

10.  The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status.

Authors:  Gilles Pomier-Layrargues; Louis Bouchard; Michel Lafortune; Julien Bissonnette; Dave Guérette; Pierre Perreault
Journal:  Int J Hepatol       Date:  2012-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.